SPRINGFIELD, Ill., Aug. 09, 2017 -- H. D. Smith, the largest independent wholesaler in the U.S. and a leading pharmaceutical brand support company, today announced the winners of its annual Trading Partners of the Year awards, honoring select pharmaceutical and health products manufacturers. These organizations partner with H. D. Smith, collaborating to grow the industry and advance patient care. Each award winner is recognized based on criteria including trade volume, trade policies and overall sales, for excellence across each key H. D. Smith product areas. This year’s Trading Partners of the Year are:
|
|||
- Brand and Specialty Pharmaceuticals: Allergan
- Generic Pharmaceuticals: Alvogen, Inc.
- Health, Beauty and Wellness Products: Prestige Brands, Inc.
- Home Healthcare Products: Drive DeVilbiss Healthcare
New this year, H. D. Smith recognized individual representatives through a Trading Partner Representative of the Year award in each category. This award honors vendor trade representatives who support H. D. Smith through managing supply chain inventory, driving profitability, supporting marketing efforts and more. This year’s recipients are:
- Brand and Specialty Pharmaceuticals: Italo Pennella – Impax Laboratories, Inc.
- Generic Pharmaceuticals: Jane Williams – Apotex Corp.
- Health, Beauty and Wellness Products: Dan Rozumalski – Salvatori-Scott, Inc.
- Home Healthcare Products: Jim Ripperger – First Quality Healthcare
The awards were presented during the 2017 H. D. Smith National Sales & Management Conference, which emphasizes the company’s position to partner and innovate within the ever-evolving healthcare industry to ensure the nation’s specialty and retail pharmacies have access to essential products.
“H. D. Smith’s success in the market can be attributed to leveraging best practices in the supply chain to improve our already strong relationships with industry partners,” said Chris Smith, president and chief executive officer of H. D. Smith. “We honor our trading partners each year with these awards as a way to express our appreciation and show how important their partnership is to us.”
The company’s 19th annual meeting epitomizes the lasting relationships that exist between H. D. Smith and its partners.
“Our alliance with trading partners is not only important to H. D. Smith, but it is also vital to be the partner the supply chain needs,” said Dale Smith, chairman and chief executive officer of H. D. Smith Holding Company. “We strive to focus on our customers’ profitability and sustaining independent pharmacy, while driving cost out of the system. These mutual initiatives cannot happen without the strong relationships H. D. Smith cultivates with our trading partners.”
Founded in 1954, the collective H. D. Smith companies equip healthcare providers and pharmaceutical manufacturers with an integrated set of solutions designed to advance the future of healthcare. Connecting the pharmaceutical supply chain for better patient care, services range from traditional and specialty product distribution and third party logistics to patient adherence, reimbursement and brand support services. Companies include H. D. Smith, Smith Medical Partners, Triplefin, CompleteCare Pharmacy, Valley Wholesale Drug Co. and Arete Pharmacy Network. Visit hdsmithcompanies.com for more information.
Contact:
Sarah Kinkade
217.747.0672
[email protected]
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/720730c1-0571-460e-ad73-2d27cd546ab7


FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
OpenAI Explores Massive Funding Round at $750 Billion Valuation
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 



